U.S. Hemophilia Treatment Market is driven by rising demand for novel therapies
The U.S. hemophilia treatment market comprises various products such as coagulation factors concentrates, desmopressin, and antifibrinolytics which are used to treat patients diagnosed with hemophilia A and hemophilia B. Treatment options in hemophilia focus on preventing excessive bleeding and providing adequate clotting factor levels. Recombinant coagulation factors have revolutionized...
0 Commentarios 0 Acciones 272 Views 0 Vista previa